These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 35216022

  • 1. Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection.
    Kang HJ, Chu KB, Yoon KW, Eom GD, Mao J, Kim MJ, Lee SH, Moon EK, Quan FS.
    Viruses; 2022 Feb 18; 14(2):. PubMed ID: 35216022
    [Abstract] [Full Text] [Related]

  • 2. Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection.
    Quan FS, Kim MC, Lee BJ, Song JM, Compans RW, Kang SM.
    Virology; 2012 Sep 01; 430(2):127-35. PubMed ID: 22658901
    [Abstract] [Full Text] [Related]

  • 3. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.
    Wu CY, Yeh YC, Chan JT, Yang YC, Yang JR, Liu MT, Wu HS, Hsiao PW.
    PLoS One; 2012 Sep 01; 7(8):e42363. PubMed ID: 22879951
    [Abstract] [Full Text] [Related]

  • 4. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ, Gabbard JD, Li Z, Dlugolenski DA, Johnson SK, Tripp RA, He B, Tompkins SM.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931689
    [Abstract] [Full Text] [Related]

  • 5. Vaccine Efficacy Induced by 2009 Pandemic H1N1 Virus-Like Particles Differs from that Induced by Split Influenza Virus.
    Lee GJ, Chu KB, Inn KS, Moon EK, Quan FS.
    Immunol Invest; 2020 Oct 01; 49(7):781-793. PubMed ID: 31774021
    [Abstract] [Full Text] [Related]

  • 6. Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
    Smith GE, Sun X, Bai Y, Liu YV, Massare MJ, Pearce MB, Belser JA, Maines TR, Creager HM, Glenn GM, Flyer D, Pushko P, Levine MZ, Tumpey TM.
    Virology; 2017 Sep 01; 509():90-97. PubMed ID: 28624679
    [Abstract] [Full Text] [Related]

  • 7. Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Kim KH, Jung YJ, Lee Y, Park BR, Oh J, Lee YN, Kim MC, Jeeva S, Kang SM.
    Virology; 2020 Nov 01; 550():51-60. PubMed ID: 32882637
    [Abstract] [Full Text] [Related]

  • 8. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
    Skarlupka AL, Bebin-Blackwell AG, Sumner SF, Ross TM.
    J Virol; 2021 Aug 10; 95(17):e0075921. PubMed ID: 34160258
    [Abstract] [Full Text] [Related]

  • 9. Highly immunogenic influenza virus-like particles containing B-cell-activating factor (BAFF) for multi-subtype vaccine development.
    Hong JY, Chen TH, Chen YJ, Liu CC, Jan JT, Wu SC.
    Antiviral Res; 2019 Apr 10; 164():12-22. PubMed ID: 30738089
    [Abstract] [Full Text] [Related]

  • 10. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.
    J Virol; 2015 Jul 10; 89(14):7224-34. PubMed ID: 25948745
    [Abstract] [Full Text] [Related]

  • 11. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA.
    J Virol; 2017 Oct 15; 91(20):. PubMed ID: 28768855
    [Abstract] [Full Text] [Related]

  • 12. Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.
    Menne Z, Pliasas VC, Compans RW, Glover S, Kyriakis CS, Skountzou I.
    Virology; 2021 Oct 15; 562():197-208. PubMed ID: 34375782
    [Abstract] [Full Text] [Related]

  • 13. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y, Boltz D, Sarawar S, Kawaoka Y, Neumann G, Bilsel P.
    Vaccine; 2017 Jul 24; 35(33):4177-4183. PubMed ID: 28668565
    [Abstract] [Full Text] [Related]

  • 14. Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice.
    Ren Z, Zhao Y, Liu J, Ji X, Meng L, Wang T, Sun W, Zhang K, Sang X, Yu Z, Li Y, Feng N, Wang H, Yang S, Yang Z, Wang Z, Gao Y, Xia X.
    Vaccine; 2018 Sep 25; 36(40):5990-5998. PubMed ID: 30172635
    [Abstract] [Full Text] [Related]

  • 15. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L, Kays SK, Zimmer G, von Messling V.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925654
    [Abstract] [Full Text] [Related]

  • 16. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A.
    Vaccine; 2016 Jun 17; 34(29):3371-80. PubMed ID: 27155499
    [Abstract] [Full Text] [Related]

  • 17. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C, Tian G, Chen X, Liu Q, Ma J, Xu S, Li X, Chen H, Cao Y.
    Virus Res; 2015 Jan 02; 195():35-42. PubMed ID: 25312452
    [Abstract] [Full Text] [Related]

  • 18. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
    Tao P, Luo M, Zhu D, Qu S, Yang Z, Gao M, Guo D, Pan Z.
    Viral Immunol; 2009 Jul 02; 22(4):273-81. PubMed ID: 19594398
    [Abstract] [Full Text] [Related]

  • 19. Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.
    Zhang L, Lu J, Chen Y, Shi F, Yu H, Huang C, Cui L, Shi Z, Jiao Y, Hu Y.
    Viruses; 2015 Aug 04; 7(8):4369-84. PubMed ID: 26248076
    [Abstract] [Full Text] [Related]

  • 20. Preparation of quadri-subtype influenza virus-like particles using bovine immunodeficiency virus gag protein.
    Tretyakova I, Hidajat R, Hamilton G, Horn N, Nickols B, Prather RO, Tumpey TM, Pushko P.
    Virology; 2016 Jan 04; 487():163-71. PubMed ID: 26529299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.